Company Filing History:
Years Active: 2011-2021
Title: Yusuke Yamazaki: Innovator in Pharmaceutical Chemistry
Introduction
Yusuke Yamazaki is a prominent inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of seven patents. His work focuses on developing innovative compounds that have therapeutic applications.
Latest Patents
Yamazaki's latest patents include the 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative. This compound exhibits BRD4 inhibitory activity, making it useful as a medicament, particularly for diseases associated with BRD4. Another notable patent is for the [4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound. This invention relates to quinoxalin-2-one compounds that have glucocorticoid receptor agonist activity, serving as potential therapeutic agents for related diseases.
Career Highlights
Yusuke Yamazaki has worked with reputable companies in the pharmaceutical industry, including Santen Pharmaceutical Co., Ltd. and Ayumi Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Yamazaki has collaborated with notable colleagues such as Minoru Yamamoto and Hiroyuki Mogi. These partnerships have contributed to his success in the field and have facilitated the advancement of his research.
Conclusion
Yusuke Yamazaki is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic compounds. His contributions continue to impact the medical field positively.